Meteora Capital’s Calidi Biotherapeutics CLDI Stock Holding History

Meteora Capital’s Portfolio CLDI Stock Details CLDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,082	Closed	-$141K	–	257
2024 Q1	$141K	Sell	2,082 -325	-14%	-$33.2K	0.02%	160
2023 Q4	$436K	Sell	2,407 -1,207	-33%	-$324K	0.07%	151
2023 Q3	$1.44M	Buy	+3,614	New	+$3.66M	0.25%	102

Other funds holding CLDI

Red Wave Investments Dillsburg, Pennsylvania $335M AUM 15.13% 1-Year Est. Return

CPR Investments Rochester, Michigan $150M AUM 19.15% 1-Year Est. Return

RS Crum Inc Newport Beach, California $517M AUM 16.68% 1-Year Est. Return

Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $417M AUM 45.61% 1-Year Est. Return

HRT Financial New York $26B AUM 58.22% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return